Effect of in Vivo Administration of All Trans-Retinoic Acid on the Hemopoietic Cell Populations of the Spleen and Bone Marrow: Profound Strain Differences between A/J and C57BL/6J Mice

Laboratory Animal Science

Volumn 48, Issue 1, 1998, Pages 74-80

  Miller, Sandra C ^a   Kearney, Susan L ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID;

A J MOUSE; ANIMAL; ARTICLE; BONE MARROW CELL; C57BL MOUSE; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; GRANULOCYTE; HEMATOPOIETIC STEM CELL; IMMUNITY; LEUKOCYTE COUNT; LYMPHOCYTE; MALE; MONOCYTE; MOUSE; SPECIES DIFFERENCE; SPLEEN;

ANIMALS; BONE MARROW CELLS; GRANULOCYTES; HEMATOPOIETIC STEM CELLS; IMMUNITY; LEUKOCYTE COUNT; LYMPHOCYTES; MALE; MICE; MICE, INBRED A; MICE, INBRED C57BL; MONOCYTES; SPECIES SPECIFICITY; SPLEEN; TRETINOIN;

EID: 0031990693     PISSN: 00236764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Degos, L. 1994. Is acute promyelocytic leukemia a curable disease? Treatment strategy for long-term survival. Leukemia 8:6-8.
2. Warrell, R. P, Jr., P. Maslak, A. Eardley, et al. 1994. Treatment of acute promyelocytic leukemia with all trans-retinoic acid: an update of the New York experience. Leukemia 8:33-37.
3. Cornic, M., L. Delva, S. Castaigne, et al. 1994. In vitro all trans-retinoic acid ( ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia. Leukemia 8:16-19.
4. Seiter, K., W. H. Miller, Jr., E. J. Feldman, et al. 1995. Pilot study of all trans-retinoic acid as post-remission therapy in patients with acute promyelocytic leukemia. Leukemia 9:15-18.
5. Tallman, M. S. 1996. Differentiating therapy with all transretinoic acid in acute myeloid leukemia. Leukemia 10:12-15.
6. Chomienne, C., P. Fenaux, and L. Degos. 1996. Retinoid differentiation therapy in promyelocytic leukemia. FASEB J. 10:1025-1030.
7. Spencer-Green, G. 1994. Retinoic acid effects on endothelial cell function: interaction with Interleukin 1. Clin. Immunol. Immunopathol. 72:53-61.
8. Smeland, E. B., L. Rusten, S. E. W. Jacobsen, et al. 1994. All trans-retinoic acid directly inhibits granulocyte colonystimulating-induced proliferation of CD34+ human hematopoietic progenitor cells. Blood 84:2940-2945.
9. Grande, A., R. Manfredini, E. Tagliafico, et al. 1995. All trans-retinoic acid induces simultaneously granulocytic differentiation and expression of inflammatory cytokines in HL-60 cells. Exp. Hematol. 23:117-125.
10. Vieira, A. V., W. J. Schneider, and P. M. Vieira. 1995. Retinoids: transport, metabolism, and mechanisms of action. J. Endocrinol. 146:201-207.
11. Zauli, G., G. Visani, M. Vitale, et al. 1995. All trans-retinoic acid shows multiple effects on the survival, proliferation and differentiation of human fetal CD34+ hemopoietic progenitor cells. Br. J. Haematol. 90:274-282.
12. Mangelsdorf, D. J., E. S. Ong, J. A, Dyck, et al. 1996. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 345:224-229.
13. Petkovich, M., N. J. Brand, A. Krust, et al. 1987. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330:444-450.
14. Gross, V., P. M. Villiger, B. Zhang, et al. 1993. Retinoic acid inhibits interleukin-1: induced cytokine synthesis in human monocytes. J. Leukoc. Biol. 54:125-132.
15. Ogata, A., N. Nishimoto, Y. Shima, et al. 1994. Inhibitory effect of all trans-retinoic acid on the growth of freshly isolated myeloma cells via interference with interleukin-6 signal transduction. Blood 84:3040-3046.
16. Tokuyama, H., and Y. Tokuyama. 1995. Endogenous cytokine expression profiles in retinoid acid-induced IgA production by LPS-stimulated murine splenocytes. Cell. Immunol. 166:247-253.
17. Herberman, R. B., M. E. Nunn, and D. Larvin. 1975. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int. J. Cancer 16:216-229.
18. Haller, O. A., M. Gidlund, J. T. Kurnich, et al. 1978. In vivo generation of mouse natural killer cells: role of spleen and thymus. Scand. J. Immunol. 8:207-213.
19. Kaminisky, S. G., I. Nakamura, and G. Cudkowicz. 1983. Selective defect of natural killer and killer cell activity against lymphomas in SJL mice: low responsiveness to interferon inducers. J. Immunol. 130:1980-1984.
20. Itoh, K., R. Suzuki, Y. Umezu, et al. 1982. Studies of murine large granular lymphocytes. II. Tissue, strain and age distributions of LGL and LAL. J. Immunol. 129:395-400.
21. Cheers, C., and I. F. C. McKenzie. 1978. Resistance and susceptibility of mice to bacterial infection: genetics of listeriosis. Infect. Immun. 19:755-762.
22. Pennington, J. E., and R. M. Williams. 1979. Influence of genetic factors on natural resistance of mice to Pseudomonas aeruginosa. J. Infect. Dis. 139:396-400.
23. Brown, I. N., A. A. Glynn, and J. Plant. 1982. Inbred mouse strain resistance to Mycobacterium lepraemurium follows the Ity/Lsh pattern. Immunology 46:149-156.
24. Nesbitt, M. N., and E. Skamene. 1984. Recombinant inbred mouse strains derived from A/J and C57BL/6J: a tool for the study of genetic mechanisms in host resistance to infection and malignancy. J. Leukoc. Biol. 36:357-364.
25. Yoshida, A., Y. Koide, M. Uchijima, et al. 1995. Dissection of strain difference in acquired protective immunity against Mycobacterium bovis Calmette-Guerin Bacillus (BCG). Macrophages regulate the susceptibility through cytokine network and the induction of nitric oxide synthase. J. Immunol. 155:2057-2066.
26. Goettsch, W., Y. Hatori, and R. P. Sharma. 1992. Adjuvant activity of all trans-retinoic acid in C57BL/6 mice. Int. J. Immunopharmacol. 14:143-150.
27. Achkar, C., J. M. Bentel, J. F. Boylan, et al. 1994. Differences in pharmacokinetic properties of orally administered all trans-retinoic acid on 9-cis-retinoic acid in the plasma of nude mice. Drug Metab. Dispos. 22:451-458.
28. Kalin, J. R., M. J. Wells, and D. L. Hill. 1984 Effects of phenobarbital, 3-methylcholanthrene, and retinoid pre-treatment on disposition of orally administered retinoids in mice. Drug Metab. Dispos. 12:63-74.
29. Apfel, C., M. Crettaz, G. Siegenthaler, et al. 1991. Synthetic retinoids: differential binding to retinoic acid receptors, p. 110-120. In J-H. Saurat (ed.), Retinoids: 10 years on. Karger, Basel.
30. Degos, L., C. Chomienne, M. T. Daniel, et al. 1991. All transretinoic acid in acute promyelocytic leukemia, p. 121-129. In J-H. Saurat (ed.), Retinoids: 10 years on. Karger, Basel.
31. Morley, A., and F. Stohlman, Jr. 1970. Studies on the regulation of granulopoiesis. I. The response to neutropenia. Blood 35:312-321.
32. LoBue, J. 1970. Analysis of normal granulocyte production and release, vol. 2. In S. Gordon (ed.), Regulation of hematopoiesis. Appleton-Century-Crofts, New York.
33. Prasse, K. W., R. C. Seagrave, M. L. Kaeberle, et al. 1973. A model of granulopoiesis in cats. Lab. Invest. 28:292-299.
34. Reeve, J. 1973. An analogue model of granulopoiesis for the analysis of isotopic and other data obtained in the non-steady state. Br. J. Haematol. 25:15-32.
35. Osmond, D. G., S. C. Miller, and Y. Yoshida. 1973. Kinetic and hemopoietic properties of lymphoid cells in the bone marrow, p. 131-156. In G. E. W. Wolstenholms and M. O'Connor (ed.), Hemopoietic stem cells (CIBA Foundation Symposium). Elsevier Excerpta Medica North-Holland, Amsterdam.
36. Miller, S. C., and D. G. Osmond. 1973. The proliferation of lymphoid cells in guinea pig bone marrow. Cell Tissue Kinet. 6:259-269.
37. Miller, S. C., and D. G. Osmond. 1974. Quantitative changes with age in bone marrow cell populations of C3H mice. Exp. Hematol. 2:227-236.
38. Smeby, W., and H. B. Benestad. 1980. Stimulation of murine granulopoiesis. Blut 41:47-60.
39. Miller, S. C. 1992. Age-related differences in the effect of in vivo administration of indomethacin on hemopoietic cell lineages of the spleen and bone marrow of mice. Experientia 48:674-678.
40. Whitelaw, D. M., M. F. Bell, and H. F. Batho. 1968. Monocyte kinetics: observations after pulse labelling. J. Cell. Physiol. 72:65-71.
41. Nichols, B. A., D. F. Bainton, and M. G. Farquhar. 1971. Differentiation of monocytes: origin, nature and fate of their azurophil granules. J. Cell Biol. 50:498-515.
42. Norris, D. A., R. Osborn, W. Robinson, et al. 1987. Isotretinoin produces significant inhibition of monocyte and neutrophil chemotaxis in vivo in patients with cystic acne. J. Invest. Dermatol. 89:38-43.
43. Wahl, L. M., and L. Lampel. 1987. Regulation of human peripheral blood monocyte collagenase by prostaglandins and anti-inflammatory drugs. Cell. Immunol. 105:411-422.
44. Goldman, R. 1984. Effect of retinoic acid on the proliferation and phagocytic capability of murine macrophage-like cell lines. J. Cell. Physiol. 120:91-102.